SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-21-011799
Filing Date
2021-05-17
Accepted
2021-05-17 15:33:24
Documents
55
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 500638
2 ex10-1.htm EX-10.1 24277
3 ex31-1.htm EX-31.1 17591
4 ex31-2.htm EX-31.2 17336
5 ex32-1.htm EX-32.1 9733
  Complete submission text file 0001493152-21-011799.txt   2992700

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE ptix-20210331.xml EX-101.INS 424007
7 XBRL SCHEMA FILE ptix-20210331.xsd EX-101.SCH 39530
8 XBRL CALCULATION FILE ptix-20210331_cal.xml EX-101.CAL 43063
9 XBRL DEFINITION FILE ptix-20210331_def.xml EX-101.DEF 164384
10 XBRL LABEL FILE ptix-20210331_lab.xml EX-101.LAB 288658
11 XBRL PRESENTATION FILE ptix-20210331_pre.xml EX-101.PRE 230315
Mailing Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010
Business Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010 (212) 994-8200
Protagenic Therapeutics, Inc.\new (Filer) CIK: 0001022899 (see all company filings)

IRS No.: 061390025 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-12555 | Film No.: 21929895
SIC: 7389 Services-Business Services, NEC